Abstract

Previous research finds a positive and significant relation between current increases in R&D expenditures and future abnormal stock returns. While the existence of this anomalous pattern is well-established, its underlying causes are the subject of much debate. Recent research also shows that transaction costs can lead to apparent market anomalies such as the post-earnings-announcement drift. We combine these two lines of research and posit that the positive relation between R&D increases and future abnormal stock returns is due to transaction costs. Consistent with this hypothesis, we find that abnormal returns on R&D-based, zero-net-investment portfolios disappear after incorporating standard measures of transaction costs. Overall, our results show that the R&D-abnormal return anomaly is more likely due to transaction costs than to the alternative hypotheses of market inefficiency or omitted risk factors.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.